Bacteroides fragilis CIP 105892 is a mesophilic, Gram-negative, rod-shaped prokaryote of the family Bacteroidaceae.
Gram-negative rod-shaped mesophilic| @ref 20215 |
|
|
| Domain Pseudomonadati |
| Phylum Bacteroidota |
| Class Bacteroidia |
| Order Bacteroidales |
| Family Bacteroidaceae |
| Genus Bacteroides |
| Species Bacteroides fragilis |
| Full scientific name Bacteroides fragilis (Veillon and Zuber 1898) Castellani and Chalmers 1919 (Approved Lists 1980) |
| Synonyms (3) |
| @ref | Gram stain | Cell shape | Motility | |
|---|---|---|---|---|
| 39381 | negative | rod-shaped |
| @ref | Name | Growth | Composition | Medium link | |
|---|---|---|---|---|---|
| 39381 | MEDIUM 6 - Columbia agar with 10 % horse blood | Distilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml) | |||
| 39381 | CIP Medium 20 | Medium recipe at CIP | |||
| 39381 | CIP Medium 6 | Medium recipe at CIP |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 39381 | positive | growth | 37 | mesophilic |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 39381 | 17057 ChEBI | cellobiose | - | degradation | |
| 39381 | 15824 ChEBI | D-fructose | + | degradation | |
| 39381 | 17634 ChEBI | D-glucose | + | degradation | |
| 39381 | 65327 ChEBI | D-xylose | + | degradation | |
| 39381 | 4853 ChEBI | esculin | + | hydrolysis | |
| 39381 | 17716 ChEBI | lactose | + | degradation | |
| 39381 | 17306 ChEBI | maltose | + | degradation | |
| 39381 | 17632 ChEBI | nitrate | - | reduction | |
| 39381 | 17632 ChEBI | nitrate | + | respiration | |
| 39381 | 16301 ChEBI | nitrite | - | reduction | |
| 39381 | 17814 ChEBI | salicin | - | degradation | |
| 39381 | 17992 ChEBI | sucrose | + | degradation |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | + | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | + | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 39381 | amylase | - | ||
| 68382 | beta-galactosidase | + | 3.2.1.23 | from API zym |
| 39381 | beta-galactosidase | + | 3.2.1.23 | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | + | 3.2.1.31 | from API zym |
| 39381 | caseinase | - | 3.4.21.50 | |
| 39381 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 39381 | gelatinase | - | ||
| 39381 | lecithinase | - | ||
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 39381 | lipase | - | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | + | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 39381 | oxidase | - | ||
| 39381 | protease | - | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 39381 | tween esterase | - | ||
| 39381 | urease | - | 3.5.1.5 | |
| 68382 | valine arylamidase | - | from API zym |
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 39381 | 2 | Risk group (French classification) |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| A highly conserved SusCD transporter determines the import and species-specific antagonism of Bacteroides ubiquitin homologues. | Tong M, Xu J, Li W, Jiang K, Yang Y, Chen Z, Jiao X, Meng X, Wang M, Hong J, Long H, Liu SJ, Lim B, Gao X. | Nat Commun | 10.1038/s41467-024-53149-w | 2024 | ||
| Metabolism | A Common Pathway for Activation of Host-Targeting and Bacteria-Targeting Toxins in Human Intestinal Bacteria. | Bao Y, Verdegaal AA, Anderson BW, Barry NA, He J, Gao X, Goodman AL. | mBio | 10.1128/mbio.00656-21 | 2021 | |
| Dissecting Gut-Microbial Community Interactions using a Gut Microbiome-on-a-Chip. | Lee J, Menon N, Lim CT. | Adv Sci (Weinh) | 10.1002/advs.202302113 | 2024 | ||
| KRAS mutations promote the intratumoral colonization of enterotoxigenic bacteroides fragilis in colorectal cancer through the regulation of the miRNA3655/SURF6/IRF7/IFNbeta axis. | Chen Y, Liu S, Tan S, Zheng Y, Chen Y, Yang C, Lin S, Mi Y, Li W. | Gut Microbes | 10.1080/19490976.2024.2423043 | 2024 | ||
| The Bacteroides fragilis pathogenicity island links virulence and strain competition. | Casterline BW, Hecht AL, Choi VM, Bubeck Wardenburg J. | Gut Microbes | 10.1080/19490976.2017.1290758 | 2017 | ||
| Metabolism | A Two-Component System Regulates Bacteroides fragilis Toxin to Maintain Intestinal Homeostasis and Prevent Lethal Disease. | Hecht AL, Casterline BW, Choi VM, Bubeck Wardenburg J. | Cell Host Microbe | 10.1016/j.chom.2017.08.007 | 2017 | |
| Enzymology | Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait. | Jamal W, Khodakhast FB, AlAzmi A, Soki J, AlHashem G, Rotimi VO. | BMC Microbiol | 10.1186/s12866-020-1703-4 | 2020 | |
| Human gut bacteria contain acquired interbacterial defence systems. | Ross BD, Verster AJ, Radey MC, Schmidtke DT, Pope CE, Hoffman LR, Hajjar AM, Peterson SB, Borenstein E, Mougous JD. | Nature | 10.1038/s41586-019-1708-z | 2019 | ||
| Metabolism | Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice. | Choi VM, Herrou J, Hecht AL, Teoh WP, Turner JR, Crosson S, Bubeck Wardenburg J. | Nat Med | 10.1038/nm.4077 | 2016 | |
| Distribution, detection of enterotoxigenic strains and antimicrobial drug susceptibility patterns of bacteroides fragilis group in diarrheic and non-diarrheic feces from brazilian infants. | Ferreira DP, Silva VL, Guimaraes DA, Coelho CM, Zauli DA, Farias LM, Carvalho MA, Diniz CG. | Braz J Microbiol | 10.1590/s1517-83822010000300010 | 2010 | ||
| Human symbionts inject and neutralize antibacterial toxins to persist in the gut. | Wexler AG, Bao Y, Whitney JC, Bobay LM, Xavier JB, Schofield WB, Barry NA, Russell AB, Tran BQ, Goo YA, Goodlett DR, Ochman H, Mougous JD, Goodman AL. | Proc Natl Acad Sci U S A | 10.1073/pnas.1525637113 | 2016 | ||
| Enzymology | Occurrence of Bacteroides fragilis enterotoxin gene-carrying strains in Germany and the United States. | Claros MC, Claros ZC, Tang YJ, Cohen SH, Silva J, Goldstein EJ, Rodloff AC. | J Clin Microbiol | 10.1128/jcm.38.5.1996-1997.2000 | 2000 | |
| Enzymology | Vaginal carriage of enterotoxigenic Bacteroides fragilis in pregnant women. | Leszczynski P, van Belkum A, Pituch H, Verbrugh H, Meisel-Mikolajczyk F. | J Clin Microbiol | 10.1128/jcm.35.11.2899-2903.1997 | 1997 | |
| Characterization of enterotoxigenic Bacteroides fragilis by a toxin-specific enzyme-linked immunosorbent assay. | Van Tassell RL, Lyerly DM, Wilkins TD. | Clin Diagn Lab Immunol | 10.1128/cdli.1.5.578-584.1994 | 1994 | ||
| Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole. | de Freitas MC, Resende JA, Ferreira-Machado AB, Saji GD, de Vasconcelos AT, da Silva VL, Nicolas MF, Diniz CG | Front Microbiol | 10.3389/fmicb.2016.01465 | 2016 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #39381 | Collection of Institut Pasteur ; Curators of the CIP; CIP 105892 |
| #68382 | Automatically annotated from API zym . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive138259.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data